{"slideshow_credits": null, "snippet": "The drug maker Mylan, which rejected one offer and was itself rebuffed on another, may be overpaying for the Swedish company Meda.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2016/02/12/business/dealbook/mylans-new-deal-may-not-be-the-one-shareholders-wanted.html", "lead_paragraph": "The drug maker Mylan, which rejected one offer and was itself rebuffed on another, may be overpaying for the Swedish company Meda.", "headline": {"main": "Mylan\u2019s New Deal May Not Be the One Shareholders Wanted", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "56bce0f738f0d810e6a1a1c3", "word_count": "343", "multimedia": [], "pub_date": "2016-02-12T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Mylan Inc", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Meda AB", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Teva Pharmaceutical Industries Ltd", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}